Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.
about
Barriers to a cure for HIV in womenPre-exposure prophylaxis to prevent HIV infection: current status, future opportunities and challengesPreventing HIV infection: pre-exposure and postexposure prophylaxisPractical guidance for nonoccupational postexposure prophylaxis to prevent HIV infection: an editorial reviewRecent developments in human immunodeficiency virus-1 latency researchAntiretroviral pharmacology in mucosal tissuesHIV-1 RNA levels and antiretroviral drug resistance in blood and non-blood compartments from HIV-1-infected men and women enrolled in AIDS clinical trials group study A5077Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy.Pharmacokinetics of antiretrovirals in genital secretions and anatomic sites of HIV transmission: implications for HIV prevention.Dual quantification of dapivirine and maraviroc in cervicovaginal secretions from ophthalmic tear strips and polyester-based swabs via liquid chromatographic-tandem mass spectrometric (LC-MS/MS) analysisCurrent perspectives in HIV post-exposure prophylaxis.Anogenital HIV RNA in Thai men who have sex with men in Bangkok during acute HIV infection and after randomization to standard vs. intensified antiretroviral regimens.Detection of Simian Immunodeficiency Virus in Semen, Urethra, and Male Reproductive Organs during Efficient Highly Active Antiretroviral TherapyImperfect drug penetration leads to spatial monotherapy and rapid evolution of multidrug resistance.Simultaneous plasma and genital pharmacokinetics and pharmacodynamics of atazanavir and efavirenz in HIV-infected women starting therapy.Comparing genotoxic signatures in cord blood cells from neonates exposed in utero to zidovudine or tenofovir.Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells.Relationship Between Genital Drug Concentrations and Cervical Cellular Immune Activation and Reconstitution in HIV-1-Infected Women on a Raltegravir Versus a Boosted Atazanavir Regimen.Emtricitabine seminal plasma and blood plasma population pharmacokinetics in HIV-infected men in the EVARIST ANRS-EP 49 study.Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized TrialPharmacokinetic modelling of efavirenz, atazanavir, lamivudine and tenofovir in the female genital tract of HIV-infected pre-menopausal women.Practical Considerations For Developing Nucleoside Reverse Transcriptase Inhibitors.Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand.Basolateral uptake of nucleosides by Sertoli cells is mediated primarily by equilibrative nucleoside transporter 1Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.Antiretroviral drug transporters and metabolic enzymes in human testicular tissue: potential contribution to HIV-1 sanctuary site.Shedding of HIV and human herpesviruses in the semen of effectively treated HIV-1-infected men who have sex with men.Tissue reservoirs of HIVShort communication: Use of raltegravir in late-presenting HIV-infected pregnant women.Antiretroviral bioanalysis methods of tissues and body biofluids.Cervicovaginal HIV-1 shedding in women taking antiretroviral therapy in Burkina Faso: a longitudinal study.Vaginal HIV-1 shedding among HIV-1 infected women in the current era of combined antiretroviral therapy: A cross sectional study.Attacking the HIV reservoir from the immune and viral perspective.Urological aspects of HIV and AIDS.Understanding HIV compartments and reservoirs.Applications of physiologically based pharmacokinetic modeling for the optimization of anti-infective therapies.Mechanisms of HIV persistence in HIV reservoirs.Population Pharmacokinetic Modeling of Tenofovir in the Genital Tract of Male HIV-Infected Patients.HIV Trafficking Between Blood and Semen During Early Untreated HIV Infection.Patterns of residual HIV-1 RNA shedding in the seminal plasma of patients on effective antiretroviral therapy.
P2860
Q26768632-F71EA8F2-F793-44B1-BEA6-6EC1088DD526Q26825641-D8A8E485-E9E3-48E6-9EDD-93868915F254Q26828445-70A031A4-96B0-4AE2-80E5-87CBCED74E2EQ26853055-CAE8AE4F-F0F8-4729-A385-A23E5F361DA4Q27013114-DAE8E5F5-3569-4D38-B6C9-09F2D3F27E57Q27014675-C8ADB1E0-0677-4803-B4B3-16FB889CD2A8Q28541918-FFB602AC-F06E-49E7-BB7D-2989E16418DFQ33714594-42EAA6C1-A131-4ED2-95C9-C81CF84EE14DQ33888718-0B2B216C-738D-4A13-A4C9-72B67F411E31Q34085477-2DF140C1-2F60-4140-8A00-B1E377AD6484Q34434815-50714253-F6AF-4ED2-94E0-86B35FCE5957Q35588077-09FCE0A5-31B1-42F7-986F-E45F48B23233Q35641179-3F8D83BC-1F9D-45C8-B2E6-4AACCFA6D4B8Q35699612-18DD5776-EEDF-41F5-B71F-21C13894FFAAQ35706140-95CC8AD2-AC50-46CD-B29C-04FDFDB99E41Q35853818-92FDCC7C-85C7-4AB6-8859-9A321A62E7B4Q36075888-68A8FCA1-9CB7-441F-AF84-66CBDB46A7CAQ36078470-8346C28A-9A30-452A-BEC3-954F84D831F4Q36158516-4583A658-A62F-43BA-AB95-A1B1A0F23507Q36166932-CE94B7DF-C316-45D1-96B9-38B30CA658C1Q36430073-76D93E45-56CB-4AFC-8149-C337D56602A7Q36727960-AD85DFBD-79B1-4DBF-8798-0CBEFB3D8B94Q36914202-22EAC218-9BC9-485F-85D8-E66628B00FA0Q36935331-1C7A769F-C036-4DCE-9FB1-8045DA4D9453Q36946237-B87B767E-F0DA-48FE-8D9F-40940DDF4FCEQ36977376-32A415D9-BC26-480B-84EB-F79ECCB55D99Q36987593-287150E7-0AD2-4105-937E-3DD4BDB42C4FQ37055454-FD0DD873-8393-438C-996D-3FFC727C4451Q37259753-35098E65-77DF-43AF-A115-98761EFE3810Q37332868-FA4BD689-0EFB-42EB-BA75-8B51BD1BCF7EQ37692477-5B3C940B-1F4A-4DE2-A57D-0B36A0A6C2E1Q37705397-FE50F10D-84D7-4399-9791-EA79EDAAC06DQ38067646-AE0ED909-176E-4F98-AADB-99086354FE38Q38156073-C78270C0-FDE8-4325-A5F0-5C6B64E6A40DQ38204313-9318F29F-EEE1-4081-B638-B9FBBF3AC722Q38420688-A7E83F44-D293-4608-97A4-2E77B2AB3986Q39106572-7C2D8C19-E837-4FBA-90B1-441C4C6326D6Q39107383-553176EF-3DC8-46DC-A232-EDFC6112D34EQ39466748-7E8AEE88-C990-4FF9-B03F-6A96394132ACQ40042087-50E9269E-CCF8-4384-BF8F-327E4B11C2C5
P2860
Pharmacokinetics of antiretroviral drugs in anatomical sanctuary sites: the male and female genital tract.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacokinetics of antiretrov ...... male and female genital tract.
@en
Pharmacokinetics of antiretrov ...... male and female genital tract.
@nl
type
label
Pharmacokinetics of antiretrov ...... male and female genital tract.
@en
Pharmacokinetics of antiretrov ...... male and female genital tract.
@nl
prefLabel
Pharmacokinetics of antiretrov ...... male and female genital tract.
@en
Pharmacokinetics of antiretrov ...... male and female genital tract.
@nl
P2093
P356
P1433
P1476
Pharmacokinetics of antiretrov ...... male and female genital tract.
@en
P2093
David J Back
Laura J Else
Saye H Khoo
Stephen Taylor
P304
P356
10.3851/IMP1919
P577
2011-01-01T00:00:00Z